Low-density Lipoprotein Receptor Deficiency Increases Susceptibility to Diet-induced Non-alcoholic Fatty Liver Disease in Mice

• 발행기관: 대한약학회
• 저자명: Sou Hyun Kim RanJu Woo Maziyar Veisi Mi Ran Byun Dae Youn Hwang Joung-Hee Kim Young-Suk Jung
• 간행물 정보: 『약학회지』제68권 제6호(2024년), 495~501쪽, 전체 7쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2024.12.31

국문 초록

Non-alcoholic steatohepatitis (NASH) is a progressive liver disease characterized by hepatic inflammation, fibrosis and, potentially, cirrhosis. Lipid dysregulation plays a significant role in the exacerbation of liver fibrosis. This study investigated the impact of a fructose, palmitate, cholesterol, and trans-fat (FPC) diet on hepatic fibrosis in Ldlrknockout (Ldlr KO) mice, a model with impaired cholesterol metabolism and elevated oxidized low-density lipoprotein. Ldlr KO mice on the FPC diet exhibited significantly slower increases in body weight and elevated serum ALT levels as compared to wild-type (WT) mice. Along with decreased high density lipoprotein cholesterol (HDL) levels, Ldlr KO mice also showed elevated serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL), and triglyceride (TG) levels, reflecting impaired cholesterol metabolism. Histopathological analysis revealed pronounced hepatocyte swelling, lipid accumulation, and more extensive fibrosis in Ldlr KO mice. TGF-β signaling pathway was notably activated in FPC-fed Ldlr KO mice, with increased levels of Smad2/3 and Smad4 proteins. Furthermore, α-SMA expression was elevated, reflecting active hepatic stellate cell activation and collagen deposition. As evidenced by elevated serum TC, LDL, and TG levels, the FPC diet significantly amplifies hepatic fibrosis in Ldlr KO mice by promoting lipid metabolism imbalance. Along with increased inflammatory responses and activation of the TGF-β signaling pathway, this lipid overload leads to enhanced collagen deposition and fibrosis. These findings highlight the critical role of cholesterol dysregulation and lipid imbalance in the progression of liver fibrosis, reinforcing the utility of Ldlr KO mice as a model for investigating NASH pathogenesis and developing potential therapeutic interventions.

목차

Introduction

Methods

Results

Discussion

Conclusion

Acknowledgments

Conflict of Interest

References

키워드

Non-alcoholic fatty liver disease Cholesterol metabolism Low-density lipoprotein receptor Liver fibrosis

참고문헌

• BMC Endocr Disord
• Cell
• Gastroenterology
• Int J Mol Sci
• Adv Drug Deliv Rev
• Best Pract Res Clin Gastroenterol
• Nature Clinical Practice Cardiovascular Medicine
• Lipids Health Dis
• Trends Endocrinol Metab
• Mol Metab
• Hepatol Commun
• Clinics (Sao Paulo)
• PLoS One
• J Gastroenterol Hepatol
• Lab Invest
• Sci Rep
• Prog Lipid Res
• Biomedicines
• Biochim Biophys Acta
• Int J Mol Sci
• Nat Metab
• Front Endocrinol (Lausanne)
• Cell Metab
• Lab Anim Res
• Acta Biochim Biophys Sin (Shanghai)
• PLoS One
• Cells
• Cold Spring Harb Perspect Biol
• J Histochem Cytochem
• Matrix Biol
• Sci Rep
• World J Gastroenterol
• Cells
• Cold Spring Harb Perspect Biol
• EMBO J